1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26807
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEvens, Andrew M-
dc.contributor.authorConnors, Joseph M-
dc.contributor.authorYounes, Anas-
dc.contributor.authorAnsell, Stephen M-
dc.contributor.authorKim, Won Seog-
dc.contributor.authorRadford, John-
dc.contributor.authorFeldman, Tatyana-
dc.contributor.authorTuscano, Joseph-
dc.contributor.authorSavage, Kerry J-
dc.contributor.authorOki, Yasuhiro-
dc.contributor.authorGrigg, Andrew P-
dc.contributor.authorPocock, Christopher-
dc.contributor.authorDlugosz-Danecka, Monika-
dc.contributor.authorFenton, Keenan-
dc.contributor.authorForero-Torres, Andres-
dc.contributor.authorLiu, Rachael-
dc.contributor.authorJolin, Hina-
dc.contributor.authorGautam, Ashish-
dc.contributor.authorGallamini, Andrea-
dc.date2021-
dc.date.accessioned2021-06-28T06:12:07Z-
dc.date.available2021-06-28T06:12:07Z-
dc.date.issued2022-
dc.identifier.citationHaematologica 2022; 107(5): 1086-1094en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26807-
dc.description.abstractEffective and tolerable treatments are needed for older patients with classical Hodgkin lymphoma (cHL). We report results for older patients with cHL treated in the large phase III ECHELON-1 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). Modified progression-free survival (PFS) per independent review facility (IRF) for older versus younger patients (aged ≥60 versus.en
dc.language.isoeng-
dc.subjectHodgkin lymphomaen
dc.subjectcanceren
dc.titleOlder patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.en
dc.typeJournal Articleen
dc.identifier.journaltitleHaematologicaen
dc.identifier.affiliationDivision of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ..en
dc.identifier.affiliationBC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver..en
dc.identifier.affiliationMemorial Sloan Kettering Cancer Center, NY..en
dc.identifier.affiliationMayo Clinic, Rochester, NY..en
dc.identifier.affiliationSungkyunkwan University School of Medicine, Samsung Medical Center, Seoul..en
dc.identifier.affiliationUniversity of Manchester and the Christie NHS Foundation Trust Manchester Academic Health Science Centre, Manchester..en
dc.identifier.affiliationJohn Theurer Cancer Center, NJ..en
dc.identifier.affiliationUC Davis Cancer Center, Sacramento, CA..en
dc.identifier.affiliationBC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver..en
dc.identifier.affiliationGenentech, South San Francisco, CA..en
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen
dc.identifier.affiliationHaematology, East Kent Hospitals, Canterbury..en
dc.identifier.affiliationMaria Sklodowska-Curie National Research Institute of Oncology, Krakow..en
dc.identifier.affiliationSeagen Inc., Bothell, WA..en
dc.identifier.affiliationMillennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited..en
dc.identifier.affiliationResearch and Innovation Department, A Lacassagne Cancer Centre, Nice..en
dc.identifier.doi10.3324/haematol.2021.278438en
dc.type.contentTexten
dc.identifier.pubmedid34162178-
local.name.researcherGrigg, Andrew P
item.fulltextWith Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Files in This Item:
File Description SizeFormat 
26807.pdf1.12 MBAdobe PDFView/Open
Show simple item record

Page view(s)

26
checked on Dec 19, 2024

Download(s)

76
checked on Dec 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.